Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Gross Margin (2016 - 2025)

Avanos Medical's Gross Margin history spans 11 years, with the latest figure at 54.52% for Q3 2024.

  • For Q3 2024, Gross Margin fell 123.0% year-over-year to 54.52%; the TTM value through Sep 2024 reached 55.51%, down 472.0%, while the annual FY2023 figure was 56.39%, 123.0% down from the prior year.
  • Gross Margin for Q3 2024 was 54.52% at Avanos Medical, down from 55.68% in the prior quarter.
  • Across five years, Gross Margin topped out at 89.39% in Q4 2021 and bottomed at 45.98% in Q2 2021.
  • The 5-year median for Gross Margin is 55.68% (2024), against an average of 57.09%.
  • The largest annual shift saw Gross Margin soared 4263bps in 2021 before it plummeted -1768bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 46.76% in 2020, then soared by 91bps to 89.39% in 2021, then fell by -20bps to 71.71% in 2022, then decreased by -24bps to 54.82% in 2023, then decreased by -1bps to 54.52% in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Gross Margin are 54.52% (Q3 2024), 55.68% (Q2 2024), and 57.07% (Q1 2024).